STAND. COM. REP. NO. 3932

 

Honolulu, Hawaii

                  

 

RE:    GOV. MSG. NO. 741

 

 

 

Honorable Ronald D. Kouchi

President of the Senate

Thirty-Second State Legislature

Regular Session of 2024

State of Hawaii

 

Sir:

 

     Your Committee on Commerce and Consumer Protection, to which was referred Governor's Message No. 741, submitting for study and consideration the nomination of: 

 

Board of Pharmacy

 

G.M. No. 741

SHERI TOKUMARU,

for a term to expire 06-30-2028,

 

begs leave to report as follows:

 

     Your Committee reviewed the personal history, resume, and statement submitted by Sheri Tokumaru for service on the Board of Pharmacy.

 

     Your Committee received testimony in support of the nomination for the reappointment of Sheri Tokumaru from the Board of Pharmacy, University of Hawaiʻi System, and four individuals. 

 

     Upon review of the testimony, your Committee finds that Dr. Tokumaru's background, experience, and dedication to community service qualify her to be reappointed to the Board of Pharmacy as a licensed pharmacist member.  Dr. Tokumaru is a board-certified, critical care pharmacist with over twenty years of pharmacy experience.  Currently, Dr. Tokumaru works as an Associate Professor and Clinical Pharmacist in the Neuroscience Intensive Care Unit at The Queen's Medical Center on Oahu.  Dr. Tokumaru also serves as the Director of Interprofessional Education and Development for the Daniel K. Inouye College of Pharmacy at the University of Hawaiʻi at Hilo.  Dr. Tokumaru is recognized by her peers as an expert in both pharmacy clinical practice and education, and testifiers commented on Dr. Tokumaru's professionalism and dedication to moving the practice of pharmacy forward through her teaching and community work.  Your Committee notes that Dr. Tokumaru has served on the Board of Pharmacy since 2019 and her extensive professional expertise as a pharmacist and educator will provide a thoughtful and considerate perspective that will continue to enhance the effectiveness of the Board.  Your Committee therefore recommends that Sheri Tokumaru be reappointed to the Board of Pharmacy based on her knowledge, experience, and commitment to public service.

 

     As affirmed by the record of votes of the members of your Committee on Commerce and Consumer Protection that is attached to this report, your Committee, after full consideration of the background, experience, and qualifications of the nominee, has found the nominee to be qualified for the position to which nominated and recommends that the Senate advise and consent to the nomination.

 

Respectfully submitted on behalf of the members of the Committee on Commerce and Consumer Protection,

 

 

 

____________________________

JARRETT KEOHOKALOLE, Chair